Medifast (MED) Current Assets (2010 - 2026)

Medifast's Current Assets history runs 17 years deep, the most recent figure standing at $202.6 million for Q1 2026.

• Quarterly Current Assets fell 5.1% year-over-year to $202.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $202.6 million (down 5.1% YoY) and the FY2025 annual result came in at $201.7 million, down 5.93% from the prior year.
• Current Assets was $202.6 million for Q1 2026 at Medifast, roughly flat from $201.7 million in the prior quarter.
• Across five years, Current Assets topped out at $324.3 million in Q1 2022 and bottomed at $201.7 million in Q4 2025.
• A 5-year average of $226.0 million and a median of $224.0 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets increased 15.04% — and 2023, when it dropped 28.97%.
• Medifast's Current Assets stood at $222.8 million in 2022, then advanced by 0.56% to $224.0 million in 2023, then fell by 4.3% to $214.4 million in 2024, then retreated by 5.93% to $201.7 million in 2025, then advanced by 0.47% to $202.6 million in 2026.
• Business Quant data shows MED's Current Assets at $202.6 million in Q1 2026, $201.7 million in Q4 2025, and $207.8 million in Q3 2025.